Teva to Pay $420M to Settle Shareholder Suit Over Generic Drug Pricing

Teva Pharmaceutical Industries Ltd. has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive scheme to fix the price of generic drugs. The settlement was disclosed on Tuesday in papers filed in federal court …

from News – Insurance Journal https://ift.tt/3fEAehW
via IFTTT